Actively Recruiting
Randomized Withdrawal Study in Patients With Schizophrenia
Led by Vanda Pharmaceuticals · Updated on 2026-01-12
400
Participants Needed
22
Research Sites
128 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this research is to evaluate the efficacy of dosing iloperidone long-acting injection (LAI) compared to placebo in preventing the exacerbation of symptoms in patients with schizophrenia.
CONDITIONS
Official Title
Randomized Withdrawal Study in Patients With Schizophrenia
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Males or females 18 to 65 years of age (inclusive)
- Diagnosed with schizophrenia per DSM-5 criteria
- In need of ongoing psychiatric treatment
You will not qualify if you...
- DSM-5 diagnosis of a psychiatric disorder other than schizophrenia that was the primary focus of treatment within the previous six months
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 22 locations
1
Vanda Investigational Site
Rogers, Arkansas, United States, 72758
Actively Recruiting
2
Vanda Investigational Site
Costa Mesa, California, United States, 92626
Actively Recruiting
3
Vanda Investigational Site
Lemon Grove, California, United States, 91945
Actively Recruiting
4
Vanda Investigational Site
Oceanside, California, United States, 92056
Actively Recruiting
5
Vanda Investigational Site
Pico Rivera, California, United States, 90660
Actively Recruiting
6
Vanda Investigational Site
San Diego, California, United States, 92123
Actively Recruiting
7
Vanda Investigational Site
Walnut Creek, California, United States, 94596
Actively Recruiting
8
Vanda Investigational Site
North Miami, Florida, United States, 33161
Actively Recruiting
9
Vanda Investigational Site
Atlanta, Georgia, United States, 30328
Actively Recruiting
10
Vanda Investigational Site
Peachtree Corners, Georgia, United States, 30071
Actively Recruiting
11
Vanda Investigational Site
Chicago, Illinois, United States, 60641
Actively Recruiting
12
Vanda Investigational Site
Flowood, Mississippi, United States, 39232
Actively Recruiting
13
Vanda Investigational Site
Saint Charles, Missouri, United States, 63304
Actively Recruiting
14
Vanda Investigational Site
St Louis, Missouri, United States, 63141
Actively Recruiting
15
Vanda Investigational Site
Las Vegas, Nevada, United States, 89119
Actively Recruiting
16
Vanda Investigational Site
Marlton, New Jersey, United States, 08053
Actively Recruiting
17
Vanda Investigational Site
Staten Island, New York, United States, 10314
Actively Recruiting
18
Vanda Investigational Site
Austin, Texas, United States, 78754
Actively Recruiting
19
Vanda Investigational Site
Houston, Texas, United States, 77081
Actively Recruiting
20
Vanda Investigational Site
Irving, Texas, United States, 75062
Actively Recruiting
21
Vanda Investigational Site
Richardson, Texas, United States, 75080
Actively Recruiting
22
Vanda Investigational Site
Bellevue, Washington, United States, 98007
Actively Recruiting
Research Team
V
Vanda Pharmaceuticals Inc.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here